BAUMER (BALM4) Main Indicators
Company Basic DataCompany | BAUMER |
Corporate Name | BAUMER S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Tradicional - BOVESPA |
Activity | Fabricação aparelhos e instrumentos p/ uso medico hospitalar e ortopedia |
Share | BALM4 |
Quote Date | 11/18/2024 |
Share Type | PN |
Last Closing | R$ 10.58 |
Quotation Factor | 1 Share |
Financial Volume | R$ 68.14 thousand |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Equipamentos |
Segment | Equipamentos |
Participation Indexes | - |
Updated 11/21/2024 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
---|
Price/Earnings | 7.33 |
Price/SBV | 0.64 |
Price/Net Sales | 0.58 |
Price/CFO | 3.97 |
Price/FCF | 5.38 |
Price/Total Assets | 0.39 |
Price/EBIT | 4.96 |
Price/Working Capital | 0.82 |
Price/NCAV | 5.18 |
EV/EBIT | 5.78 |
EV/EBITDA | 4.65 |
EV/Net Sales | 0.68 |
EV/CFO | 4.63 |
EV/FCF | 6.28 |
EV/Total Assets | 0.45 |
Company Market Cap | R$ 114.95 M |
Enterprise Value | R$ 120.84 M |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 10.58 |
Share Price Date | 11/18/2024 |
Dividend Yield | 7.34% |
Summary Income Statement Last 12 Months | |
---|
Net Revenue | R$ 178.51 M |
Gross Result | R$ 109.59 M |
EBIT | R$ 20.90 M |
Depreciation and Amortization | - R$ 5.07 M |
EBITDA | R$ 25.97 M |
Net Profit | R$ 14.14 M |
Net Profit/Share | R$ 1.44 |
Summary Income Statement Last Quarter | |
---|
Net Revenue | R$ 54.16 M |
Gross Result | R$ 34.04 M |
EBIT | R$ 9.48 M |
Depreciation and Amortization | - R$ 1.27 M |
EBITDA | R$ 10.76 M |
Net Profit | R$ 5.12 M |
Profit/Share | R$ 0.52 |
Stock Price and Stock Volume BehaviorLowest Price 52 weeks | R$ 9.11 |
Highest Price 52 weeks | R$ 11.52 |
Variation 2024 | 5.69% |
Variation 1 year | 13.29% |
Variation 2 years(total) | 18.09% |
Variation 2 years(yearly) | 8.63% |
Variation 3 years(total) | -12.47% |
Variation 3 years(yearly) | -4.34% |
Variation 4 years(total) | -31.89% |
Variation 4 years(yearly) | -9.16% |
Variation 5 years(total) | 12.48% |
Variation 5 years(yearly) | 2.38% |
Average Daily Volume (3 months) | R$ 4.45 thousand |
Updated 11/21/2024 |
Returns, Margins, and Other Measures | |
---|
Return on Initial Tangible Capital | 7.58% |
Return on Initial Invested Capital | 8.80% |
Pre-Tax Return on Initial Tangible Capital | 11.49% |
Pre-Tax Return on Initial Invested Capital | 13.33% |
Return on Initial Shareholder´s Equity | 9.62% |
Return on Initial Asset | 5.66% |
Gross Margin | 61.39% |
Net Margin | 7.92% |
EBIT Margin | 11.71% |
EBITDA Margin | 14.55% |
Initial Asset Turnover | 0.71 |
Financial Leverage | 1.65 |
Liabilities/Net Worth | 0.65 |
Net Debt/EBITDA | 0.23 |
Summary Balance Sheet | |
---|
Cash and Cash Equivalents | R$ 11.48 M |
Total Assets | R$ 269.17 M |
Short-Term Debt | R$ 1.08 M |
Long-Term Debt | R$ 16.28 M |
Gross Debt | R$ 17.36 M |
Net Debt | R$ 5.89 M |
Shareholder´s Equity | R$ 163.04 M |
Share Book Value | R$ 16.64 |
Common Shares | 4,900,000 |
Preferred Shares | 4,900,000 |
Total | 9,800,000 |
Common Shares in Treasury | 11,890 |
Preferred Shares in Treasury | 3,600 |
Total in Treasury | 15,490 |
Common Shares (Except Treasury) | 4,888,110 |
Preferred Shares (Except Treasury) | 4,896,400 |
Total (Except Treasury) | 9,784,510 |
Summary Cash Flow Statement Last 12 Months | |
---|
Operating Cash Flow | R$ 26.11 M |
Cash Flow from Investments | - R$ 1.90 M |
Financing Cash Flow | - R$ 11.09 M |
Increase (Reduction) in Cash and Equivalents | R$ 13.12 M |
Summary Cash Flow Statement Last Quarter | |
---|
Operating Cash Flow | R$ 9.42 M |
Cash Flow from Investments | R$ 1.95 M |
Financing Cash Flow | - R$ 8.10 M |
Increase (Reduction) in Cash and Equivalents | R$ 3.27 M |
Experimental CAPEX and Free Cash Flow Calculation | |
---|
CAPEX 3 months | - R$ 1.24 M |
Free Cash Flow 3 months | R$ 8.18 M |
CAPEX 12 months | - R$ 6.86 M |
Free Cash Flow 12 months | R$ 19.26 M |